The Dexamethasone Intravitreal Implant for Noninfectious Uveitis: Practice Patterns among Uveitis Specialists

Bryn M. Burkholder, Ahmadreza Moradi, Jennifer E. Thorne, James P. Dunn

Research output: Contribution to journalArticle

Abstract

Purpose: To describe the practice patterns and perceptions of uveitis specialists regarding the use of the intravitreal dexamethasone (DEX) implant for the treatment of noninfectious uveitis. Methods: We invited uveitis specialists to participate in an anonymous online survey. Results: Among the 45 respondents, 76.5% identified uveitic macular edema as the most common clinical finding for which they use the DEX implant. The most common contraindications to DEX implantation were aphakia and glaucoma requiring >2 medications. Nearly two-thirds (64.3%) felt that the advent of the DEX implant did not change the frequency with which they used the fluocinolone acetonide (FA) implant, and about one-third (32.3%) preferred to use at least one DEX implant, before committing a patient to an FA implant. Conclusions: Uveitis physicians use the DEX implant for a wide range of clinical findings and uveitic diagnoses. There was no clear consensus on preferences regarding the use of DEX versus FA implants.

Original languageEnglish (US)
Pages (from-to)444-453
Number of pages10
JournalOcular Immunology and Inflammation
Volume23
Issue number6
DOIs
StatePublished - Nov 2 2015

Keywords

  • Dexamethasone
  • Fluocinolone
  • Intravitreal implant
  • Uveitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology

Fingerprint Dive into the research topics of 'The Dexamethasone Intravitreal Implant for Noninfectious Uveitis: Practice Patterns among Uveitis Specialists'. Together they form a unique fingerprint.

  • Cite this